Navigation Links
Cheap Anti-malarial Drug

French Pharma Company Sanofi-Aventis has come out with a cheap and effective drug for malaria. Sanofi has developed the treatment in association with the Drugs// for Neglected Diseases initiative (DNDi), which is supported by global aid agency Medecins Sans Frontieres (MSF). This treatment called as ASAQ is a combination of artesunate and amodiaquine.

The earlier treatment for malaria had two tablets which had to be consumed simultaneously. But people have been missing out on one tablet in most cases. This has resulted in the malarial parasite developing a resistance to artesunate which is the main component in the malarial therapy.

But with ASAQ, the therapy is a combination of artesunate and the amodiaquine in one tablet. In children, smaller doses of ASAQ are recommended. The greatest advantage of ASAQ is that it is easily affordable. The cost of ASAQ for a three day course for adults is less than $1 and it is less than 50 cents for children under the age of 5.

Sanofi-Aventis has also decided not to patent this drug which would enable the other companies to manufacture this drug at a cheaper rate for developing nations. The cheaper price of this drug would dissuade the counterfeiters from making them as there is no profit for them in this endeavor.

Malaria as a disease kills 500 million every year and in African nations one child is killed due to malaria every 30 seconds.
JYT
'"/>




Page: 1

Related medicine news :

1. Cipro Has Cheaper Cousins to Treat Anthrax
2. A Cheap Device to Stop Snoring from New Zealand
3. Scientists Developed Cheap Way To Assess Sleep
4. Cheap Indian devices sought to treat sleep disorder
5. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
6. Inaccurate Counts with Cheap Pedometers – Researcher Find
7. Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B
8. Drug Firms Competing to Produce Cheap and Effective bird flu vaccine
9. Diabetics to get Relief from Cheaper Drugs
10. Russia Hit By Cheap Bootleg Vodka Epidemic
11. Safer ICU’s: Cheap, Simple, “Low-Tech” Steps Wrk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: